Gestational diabetes and risk of incident primary cancer: a large historical cohort study in Israel (Q44737786)

5 December 2017

Gestational diabetes and risk of incident primary cancer: a large historical cohort study in Israel (English)

1 reference

5 December 2017

0 references

0 references

2

Gabriel Chodick

1 reference

5 December 2017

Tal Sella

1

1 reference

5 December 2017

Micha Barchana

3

1 reference

5 December 2017

Anthony D Heymann

4

1 reference

5 December 2017

Avi Porath

5

1 reference

5 December 2017

Ehud Kokia

6

1 reference

5 December 2017

Varda Shalev

7

1 reference

5 December 2017

17 August 2011

1 reference

5 December 2017

Cancer Causes & Control

1 reference

5 December 2017

22

1 reference

5 December 2017

11

1 reference

5 December 2017

1513-1520

1 reference

https://scigraph.springernature.com/pub.10.1007/s10552-011-9825-5

5 December 2017

0 references

cites work

What is gestational diabetes?

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Prevalence of gestational diabetes mellitus detected by the national diabetes data group or the carpenter and coustan plasma glucose thresholds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Increasing prevalence of gestational diabetes mellitus: a public health perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

The risk of overt diabetes mellitus among women with gestational diabetes: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Abnormal glucose tolerance and the risk of cancer death in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Fasting serum glucose level and cancer risk in Korean men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Diabetes, prediabetes and cancer mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Diabetes and risk of incident cancer: a large population-based cohort study in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Cancer risk in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

A case-control study of diabetes mellitus and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Long-term risk of malignant neoplasm associated with gestational glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Gestational diabetes and the risk of breast cancer among women in the Jerusalem Perinatal Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Gestational diabetes as a risk factor for pancreatic cancer: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Criteria for screening tests for gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Serum and tissue level of insulin-like growth factor-I (IGF-I) and IGF-I binding proteins as an index of pancreatitis and pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Diabetes and risk of Non-Hodgkin's lymphoma: a meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Type 2 diabetes mellitus and risk of non-Hodgkin lymphoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Irregular menses: an independent risk factor for gestational diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Body size, weight change, and risk of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9825-5

10.1007/S10552-011-9825-5

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference